ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 150 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 24.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $22,718,000 | +60.2% | 1,204,600 | 0.0% | 2.53% | +81.4% |
| Q2 2019 | $14,178,000 | -18.3% | 1,204,600 | -5.3% | 1.40% | -11.0% |
| Q1 2019 | $17,355,000 | +190.9% | 1,271,500 | +118.5% | 1.57% | +67.2% |
| Q4 2018 | $5,965,000 | -38.4% | 582,030 | 0.0% | 0.94% | +3.1% |
| Q3 2018 | $9,690,000 | +5.4% | 582,030 | 0.0% | 0.91% | +9.9% |
| Q2 2018 | $9,196,000 | – | 582,030 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
| Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
| PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
| Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
| Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
| PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
| Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
| Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |